Chardan Capital maintains QumulusAI at Buy, lowers price target to $13 from $23
Chardan Capital kept its Buy rating on QumulusAI but reduced its price target from $23 to $13, a 43.5% cut. The new target suggests a 323.5% upside from the Nov 10 close of $3.07.
How this was made

The 30-second read
Why it matters
The downgrade suggests reduced upside expectations, potentially pressuring the stock.
Market read
Analyst price target cut may trigger short interest and affect trading activity in the micro‑cap AI sector.
What to watch
Limited coverage and low liquidity could amplify price moves.
Background
Chardan Capital revised its price target for QumulusAI, lowering it from $23 to $13, indicating a 43.5% reduction.
Market effects
None
None
None
Counterpoint
Analyst downgrade may be overly pessimistic for a niche AI play.
Key entities
- CompanyQumulusAI
AI-focused firm covered by Chardan Capital.
- AnalystChardan Capital
Research firm issuing the rating and price target.


